CIK 0001175680
- Non-accelerated filer
- Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753056237
- Phone
- +1 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- 4 Grant or award Chief Operating Officer acquired 19,384 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 250,000 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chairman & CMO acquired 166,000 shares (option exercise)
- 4 Open-market sale Chief Financial Officer sold 711,801 shares at an average $6.23 ($4,437,557)
- 4/A Open-market sale Chief Financial Officer sold 1,104,799 shares at an average $5.27 ($5,827,032)
- 4 Open-market sale Chief Financial Officer sold 1,108,799 shares at an average $5.28 ($5,849,360)
- 4 Open-market buy Director bought 193,500 shares at $2.57 ($497,295)
- 4 Open-market buy GC and Corporate Secretary bought 10,000 shares at $2.50 ($25,000)
- 4 Open-market buy Director bought 120,000 shares at $2.49 ($298,308)
- 4 Grant or award Chief Scientific Officer acquired 200,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award GC and Corporate Secretary acquired 70,000 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 200,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 100,000 shares (grant or award)
- 4 Grant or award Chairman & CMO acquired 250,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 500,000 shares (grant or award)
- 4 Gift Chairman & CMO gave 74,800 shares (gift)
Page 6 of 22 · 435 filings